TG Therapeutics, Inc. Free Cash Flow 2011–2025
TG Therapeutics, Inc. reported $-24.99M of free cash flow for fiscal 2025. That was 38.4% higher than fiscal 2024. Compared with fiscal 2020, the change was +88.4%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $-24.99M | +38.4% |
| FY 2024 | $-40.56M | -29.1% |
| FY 2023 | $-31.41M | +82.2% |
| FY 2022 | $-176.18M | +40.5% |
| FY 2021 | $-296.04M | -37.8% |
| FY 2020 | $-214.86M | -61.6% |
| FY 2019 | $-132.94M | -3.0% |
| FY 2018 | $-129.01M | -37.6% |
| FY 2017 | $-93.76M | -51.4% |
| FY 2016 | $-61.93M | -38.4% |
| FY 2015 | $-44.73M | -27.5% |
| FY 2014 | $-35.08M | -226.5% |
| FY 2013 | $-10.74M | -107.1% |
| FY 2012 | $-5.19M | -5893.9% |
| FY 2011 | $-86,577 | — |
Source: TG Therapeutics, Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open TGTX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
TG Therapeutics, Inc. reported $-24.99M of free cash flow for fiscal 2025. That was 38.4% higher than fiscal 2024. Compared with fiscal 2020, the change was +88.4%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for TG Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTG Therapeutics, Inc. — frequently asked questions
What is TG Therapeutics, Inc.'s free cash flow?
TG Therapeutics, Inc. (TGTX) reported free cash flow of $-24.99M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from TG Therapeutics, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.